The presentations are titled “Development of sd-rxRNA for Retinoblastoma Therapy” and “Novel Anti-CTGF RNAi Therapy for Treatment of Proliferative Vitreoretinopathy (PVR) and Other Ocular Disorders.”
More Articles on Ophthalmology:
InSite Vision to Present at ARVO 2013
Glaucoma Management Lens to be Presented at ARVO 2013
Alcon Earns FDA Approval for Fixed-Dose Combination Glaucoma Therapy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
